The S&P 500 gained 0.1% on Thursday, July 24, 2025, notching an all-time closing high for the fourth straight day following ...

None of the price-target hikes were particularly dramatic, but since they came from analysts already bullish on AbbVie, they ...

Investors were clearly impressed by the company's second-quarter beats, especially the one on the bottom line.

It also heralded a change in strategy, with CEO Robert Davis saying that the company is undergoing "a multiyear optimization ...

The S&P 500 and Nasdaq traded near all-time highs at midday as a strong earnings report from Alphabet lifted big tech stocks.

Trump’s tariff regime has shaken global trade — and Ireland’s critical pharma sector is bracing for long-term change ...

Shares in Danish drugmaker Novo Nordisk were down nearly 20% in pre-market trading Tuesday morning after the company cuts its sales and profit estimates.

This regulatory relief, combined with several other compelling catalysts, creates a pathway for the stock to potentially ...

West Pharmaceutical Services, Inc.'s Q2 results highlight growth driven by GLP-1 drugs and high-value products. Click for WST ...

President Donald Trump called out 17 Big Pharma CEOs over "exorbitant" drug pricing in individual letters sent out Thursday, ...

In Q2 2025, West Pharmaceutical's revenues increased by 9.17%, suggesting that the destocking effect is vanishing. Read why ...

Shares of Novo Nordisk (NYSE: NVO) are falling this week, down 33% as of 3:27 p.m. ET on Friday. The drop comes as the S&P ...